Skip to Content

THURSDAY, 05 MARCH 2026, 14:01

Top Stories

R250m Clayville housing project resumes after temporary closure

Today at 13:53 PM, via SowetanLIVE

Construction has resumed at the R250m Clayville housing project after a temporary closure due to labour and immigration contraventions, including the discovery of undocumented workers and a fake construction permit.

World

Ukraine offers drone expertise to Gulf amid Iran strikes

Today at 11:48 AM, via NPR

As Iran launches its Shahed drones at Gulf nations in retaliation for strikes by the U.S. and Israel, Ukraine offers its expertise at downing the drones Russia has lobbed at its cities for years.

World

China offers to mediate in US-Israel-Iran war

Today at 11:47 AM, via NPR

China says it will send a special envoy to the Middle East to help mediate the US-Israel-Iran war, as Chinese political elites gather in Beijing for the annual “Two Sessions.”

Business

Nedbank partnering with Crypto.com

Today at 13:38 PM, via BusinessTech

Nedbank has announced a partnership with Crypto.com, as it looks to leverage blockchain-enabled payment infrastructure.

Entertainment

PODCAST: What’s really in your sanitary pad?

Today at 13:34 PM, via The Citizen

Concerns arise when young, developing females are exposed to these products long term, which can lead to health issues in the future.

Science/Tech

DA Takes Court Action To Stop Above-Inflation Salary Hikes At Struggling City Of Johannesburg

Today at 13:14 PM, via Tech Financials

The Democratic Alliance (DA) has initiated legal action against the City of Johannesburg to halt what the party claims is the implementation of an unfunded R10 billion salary agreement. Councillor Belinda Kayser-Echeozonjoku, the DA Johannesburg Caucus Leader, on Wednesday, 4 March 2026, said her party, ”served the City with legal papers to stop the implementation […]

Health

F.D.A. Faces Upset Over Denials of New Drugs

Today at 12:01 PM, via New York Times

Agency officials promise fast reviews of new treatments while vowing they will not be a “rubber stamp” for the industry. But patients with rare diseases view recent decisions as signs that the doors are closing on their options.